Download Hospital brochure - LMA™ Better by design

No needle. No trauma.
Needle-free intranasal
drug delivery device
The unique design of LMA MAD Nasal™ enables a seal to be formed with the nostril and atomized
particles of medication to be delivered to the nasal mucosa. The particles are then absorbed
through the mucosal tissue and into the bloodstream, avoiding first pass metabolism.
Atomization spray
Soft conical plug
The spray atomizes drugs into a fine mist
of particles 30-100 microns in size.
Malleable stylet
The plug forms a seal with the nostril
preventing expulsion of fluid.
The malleable stylet allows 180°
positioning of the nasal plug.
Accurate dosing
The syringe enables the
accurate measurement of
drugs to be delivered.
Pressure
High applied pressure ensures
that drugs are atomized into a fine
mist of particles through the tip of the plug.
Managing time critical
emergency situations
Intranasal drug delivery with LMA MAD Nasal™ can be carried out by a broad range
of healthcare professionals and is an effective alternative drug delivery method, for
use with drugs approved for nasal delivery.
Needle-free drug delivery device
User-friendly device
LMA MAD Nasal™ decreases the chances of accidental
needlestick injuries both on scene and while managing patients
during transport.
LMA MAD Nasal™ is an easy and effective drug delivery device,
which enables users to deliver medication directly into the nose
from any angle.
Eliminates risk of needlestick
injury in drug delivery
At the point of drug delivery, LMA MAD Nasal™ eliminates
the risk of needlestick injuries.
There are a number of benefits associated with needle-free drug delivery:
A
ddresses concerns over blood-borne pathogens
A
broader scope of healthcare workers can deliver drugs intranasally
without having to access a vein
R
educes costs associated with needlestick injury
R
educes time spent reporting and processing needlestick injuries
Risk free from needlestick injury at
the point of drug delivery.
R
educes the amount of time off work due to needlestick injury
Time efficient drug delivery
LMA MAD Nasal™ can deliver time efficiencies in clinical practice,
leaving more time to focus on patient care.
LMA MAD Nasal™ enables healthcare professionals to:
S
pend less time preparing an IV line
Quickly and effectively prepare a dose for IN drug delivery
S
pend less time delivering drugs intravenously
Administer medication rapidly via the intranasal mucosa
LMA MAD Nasal™: Product specification
PO number
Quantity / case
Quantity / box
Description
MAD100
100
25
Intranasal mucosal atomization device with 3ml syringe
MAD100OS
100
25
Intranasal mucosal atomization device with 3ml oral syringe
MAD110
100
25
Intranasal mucosal atomization device with 1ml syringe
MAD110OS
100
25
Intranasal mucosal atomization device with 1ml oral syringe
MAD130
100
25
Intranasal mucosal atomization device with 1ml syringe
and vial adaptor
MAD130OS
100
25
Intranasal mucosal atomization device with 1ml oral syringe
and vial adaptor
MAD140
100
25
Intranasal mucosal atomization device with 3ml syringe
and vial adapter
MAD140OS
100
25
Intranasal mucosal atomization device with 3ml oral syringe
and vial adaptor
MAD300
100
25
Intranasal mucosal atomization device without syringe
Find out more about
LMA MAD Nasal
™
Clinical evidence
For the latest clinical evidence on
LMA MAD Nasal™ and LMA Atomization™,
visit www.lmaco.com/evidence
For the latest digital case reports, educational
videos and clinician testimonials on the benefits of
LMA MAD Nasal™ and LMA Atomization™, visit
www.youtube.com/LaryngealMaskAirway
For the latest news from LMA, like us on
www.facebook.com/LMAInternational
For product information and access to product
instructions for use, visit www.lmaco.com
For information on other products within the
Teleflex product portfolio, visit www.teleflex.com
TELEFLEX HEADQUARTERS INTERNATIONAL, IRELAND
Teleflex Medical Europe Ltd., IDA Business and Technology Park,
Dublin Road, Athlone, Co. Westmeath, Ireland
Phone +353 (0)9 06 46 08 00 Fax +353 (0)14 37 07 73
[email protected]
30-0309 Rev. 10/14
Distributed by:
Teleflex
www.teleflex.com
LMA
www.lmaco.com
Manufactured by:
Wolfe Tory Medical, Inc.
79 West 4500 South
Salt Lake City, Utah 84107
Consult IFU on this website:
www.LMACO.com
For use with drugs approved for nasal delivery.
Copyright © 2014 Teleflex Incorporated. All rights reserved. LMA, LMA Atomization, LMA Better by Design,
LMA MAD Nasal, LMA MAD, MAD and MAD Nasal are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates. Wolfe-Tory Medical, Inc. is a wholly owned subsidiary of Teleflex Medical.
XX XX XX – XX XX XX . XXX XX/XX . XX/X . XX XX XX